In this video, Paolo Caimi, MD, a physician and clinical investigator at Cleveland Clinic, discussed research on the use of ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...

Patients with relapsed or refractory large B-cell lymphoma who received epcoritamab or glofitamab in real-world settings ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas, and due to innovations in manufacturing, could ...

Basel: Roche has announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received 510(k) clearance from the United States Food and Drug ...

Within this category, researchers have identified 2 main cell-of-origin (COO) molecular subtypes using gene expression profiling: germinal center B-cell (GCB) and activated B-cell (ABC) subtypes. 5,6 ...

Hodgkin lymphoma is a type of lymphoma (a cancer originating ... distinct circulating and tumor-infiltrating CD4 + T cell, B cell and IL1β + monocyte/macrophage features associated with response ...

Symptoms of MCL are similar to those of many other types ... specialized tests are performed to help determine the malignancy's specific cell type of origin. MCL is a B-cell lymphoma, and MCL cells ...

Stage 4 diffuse large B-cell lymphoma (DLBCL) is a rapidly growing lymphoma affecting at least one other organ outside the lymphatic system. Cancer is the unusual growth and spread of cells within ...

B-cell lymphoma, or B-cell non-Hodgkin lymphoma ... assess the patient for swollen lymph nodes or other characteristic symptoms. Clinicians familiar with the presentation of B-cell lymphoma ...